Advanced Search

 

Study ID Status Title Patient Level Data
201514 Active not recruiting Impact of initiating maintenance treatment (MT) promptly post-chronic obstructive pulmonary disease (COPD) exacerbation in a managed care setting
201521 Recruiting Impact of Boostrix™ maternal vaccination on morbidity and mortality of pertussis disease in infants ≤6 weeks of age, in Bogota, Colombia.
201527 Completed Comparative Randomized, Single dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole from Idiazole 20mg DR tabs (GSK, Egypt)and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a Single Oral Dose Administration of each to Healthy Adults under Fasting Conditions
201528 Completed Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Rabeprazole from Raperazole 20mg DR tabs (GSK, Egypt) and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a single oral dose administration of each to healthy adults under fed conditions
201529 Completed Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil from Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
201530 Active not recruiting Qualitative Feasibility of Patient-Centered Mixed-Methods Analysis of SLE Patient Experience Trajectories: The BLISS Trials
201539 Active not recruiting A retrospective data collection of the parameters required as per Belgian reimbursement criteria in SLE patients having received belimumab
201543 Completed A multi-centre, randomised, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, and tolerability of repeat doses of inhaled GSK2269557 in adults with persistent, uncontrolled asthma
201544 Completed A single centre, three part, randomised, study to evaluate the safety, tolerability and pharmacokinetics of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to Healthy Subjects
201546 Completed 201546, A repeat-dose study of batefenterol/FF (GSK961081/GW685698) compared with placebo in the treatment of COPD
201558 Completed A single centre, single blind study to investigate the safety, tolerability and pharmacokinetics of single doses of oxytocin (GR121619) administered via an inhaled route in healthy female volunteers
201568 Completed PGx7589: PGx Investigation of Efficacy by Meta-Analysis of Dabrafenib/Trametinib Melanoma Studies BRF113710, BRF113929, BRF113683, MEK114267 and MEK115306
201580 Withdrawn A Phase II, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Proof of Concept Study with an Interim Futility Analysis of Epelsiban in Patients with Adenomyosis
201583 Completed A Phase I, Open-label, Randomized, Three-period Cross-over Study Evaluating the Effect of Cyclosporine on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects
201594 Completed An open-label study of the ease of use and correct use of placebo ELLIPTA dry powder inhaler in subjects with asthma
201595 Completed Post-hoc Analyses of Eosinophil Subgroups using Pooled Data from HZC102871 and HZC102970
201598 Recruiting An exploratory, retrospective laboratory evaluation of the humoral immune response in adults and children to the H1 HA stalk domain and other influenza A virus protein epitopes, after administration of GSK Biologicals’ pandemic influenza vaccines
201600 Not yet recruiting BOTOX Drug Use Investigation (Strabismus)
201604 Completed Patient Satisfaction and Symptom Management Goal: Survey of Japanese adult patients with bronchial asthma receiving inhaled corticosteroid-containing medications
201608 Completed PGx7592: Evaluation of the Effect of BIM Germline Variants on Pazopanib Efficacy in Patients with Cancer
201614 Completed An Open Label, Single-arm Study Evaluating a New Thermostable Formulation of FLOLAN™ in Japanese Subjects with Pulmonary Arterial Hypertension (PAH)
201624 Completed PGx7571: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB115991
201625 Completed PGx7602: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB110927
201627 Completed PGx7604: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB114242
201630 Recruiting Long term hepatitis A virus (HAV) antibody persistence in children vaccinated with 1 dose and those vaccinated with 2 doses of Havrix® in Panama

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.